References
- Cancer Facts & Figures -1995. American Cancer Society, Atlanta, GA. 1995: 9-10.
- Hermanek P, Sobin LH. In: UICC TNM classification of malignant tumours. 4th edn, 2nd rev. Springer-Verlag, Berlin, Heidelberg, New York, 1992.
- Steimberg SM, Barkin JS, Kaplan RS, Stablein DM. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer 1986; 57: 1866–1870.
- Wolmark N, Fisher B, Wiehand HS. The prognostic value of the modification of Dukes' C Class of colorectal can-cer. Ann Surg 1986; 203: 115–121.
- Kune GA, Kune S, Field B, et al. Survival in patients with large-bowel cancer. Dis Colon Rectum 1990; 33: 938–946.
- Hermanek P, Gospodarowictz MK, Henson DE, Hutter RVP, Sobin LH (Eds). In: Prognostic factors in cancer, Springer-Verlag, Berlin, Heidelberg, New York, 1995: 64-79.
- Moll R, Franke WW, Schiller DR, Geiger B, Krepler R. The catalogue of human cytokeratins: pattern of expression in normal epithelial tumors and cultured cells. Cell 1983; 21: 11–24.
- Neville AM, Bettelheim R, Price KN. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1990; 335: 1565–1568.
- Maehara Y, Baba H, Ohno S, Sugimachi K. Cytokeratin staining reveals micrometastasis in lymph nodes of early gas-tric cancer. Surgery 1995; April: 480.
- Cutait R, Alves VA, Lopes LC, et al. Restaging of col-orectal cancer based on the identification of limph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991; 34: 917–924.
- Haboubi NY, Clark P, Kaftan SM, Schoefield PF. The importance of combining xylene clearance and immunohisto-chemistry in the accurate staging of colorectal carcinoma. J R Soc Med 1992; 85: 356–358.
- Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B col-orectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 1994; 73: 563–569.
- Linderman F, Shlimok G, Dirscheld P, Witte J, Riethmuller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992; 340: 685–689.
- Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994; 172: 183–187.
- Hsu SM, Raine L, Fanger H. Use of avidin-biotin-per-oxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–580.
- Moertel CG. Chemotherapy for colorectal cancer. N Engl J Med 1994, 330: 1136–1142.
- Schlimok K, Funke I, Bock B, Schweiberer B, Witte J, Riethmuller J. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detec-tion, phenotypic characterization and prognostic significance. J Clin Oncol 1990; 8: 831–7.